Abstract
Preliminary interpretive zone diameter criteria were calculated for the 5-micrograms cefdinir disk diffusion test by using two potential MIC breakpoints (less than or equal to 0.5 and less than or equal to 1 micrograms/ml). The absolute agreement between tests ranged from 85.9 to 92.4%, and the false-susceptibility errors were principally contributed by the Enterobacter spp. (2.2% error). One proposed criterion was greater than or equal to 20-mm zone diameter (less than or equal to 1 micrograms/ml) for susceptibility and less than or equal to 16-mm zone diameter (greater than 2 micrograms/ml) for resistance to cefdinir. Clinical laboratory users of the disk diffusion method should be cautioned about the possibility of very major interpretive errors among enterobacter isolates.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Briggs B. M., Jones R. N., Erwin M. E., Barrett M. S., Johnson D. M. In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin. Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):425–434. doi: 10.1016/0732-8893(91)90069-r. [DOI] [PubMed] [Google Scholar]
- Fuchs P. C., Barry A. L., Jones R. N. Cefixime disk susceptibility test criteria. J Clin Microbiol. 1986 Oct;24(4):647–649. doi: 10.1128/jcm.24.4.647-649.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones R. N., Barry A. L. Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem. J Clin Microbiol. 1988 Apr;26(4):770–773. doi: 10.1128/jcm.26.4.770-773.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones R. N., Barry A. L. Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests. J Clin Microbiol. 1987 Sep;25(9):1796–1799. doi: 10.1128/jcm.25.9.1796-1799.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mine Y., Kamimura T., Watanabe Y., Tawara S., Matsumoto Y., Shibayama F., Kikuchi H., Takaya T., Kuwahara S. In vitro antibacterial activity of FK482, a new orally active cephalosporin. J Antibiot (Tokyo) 1988 Dec;41(12):1873–1887. doi: 10.7164/antibiotics.41.1873. [DOI] [PubMed] [Google Scholar]
- Sakamoto H., Hirose T., Nakamoto S., Hatano K., Shibayama F., Kikuchi H., Mine Y., Kuwahara S. Pharmacokinetics of FK482, a new orally active cephalosporin, in animals. J Antibiot (Tokyo) 1988 Dec;41(12):1896–1905. doi: 10.7164/antibiotics.41.1896. [DOI] [PubMed] [Google Scholar]